Puxitatug samrotecan drug-linker

Catalog No.: A41491
Drug-Linker Conjugate for ADC
Puxitatug samrotecan drug-linker is a highly specialized drug-linker conjugate designed for use in antibody-drug conjugate (ADC) applications. This compound combines a potent topoisomerase I inhibitor with a linker moiety, facilitating the targeted delivery of cytotoxic agents to neoplastic cells. Puxitatug samrotecan drug-linker enables the synthesis of ADCs such as Puxitatug samrotecan, thereby enhancing therapeutic efficacy while minimizing systemic toxicity. This reagent is essential for researchers focusing on innovative cancer therapies and targeted drug delivery systems.
Grouped product items
Size Price Stock Qty
5mg
$1,035.00
In stock
10mg
$1,765.00
In stock
25mg
$3,480.00
In stock
50mg
$5,315.00
In stock
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionPuxitatug samrotecan drug-linker is a highly specialized drug-linker conjugate designed for use in antibody-drug conjugate (ADC) applications. This compound combines a potent topoisomerase I inhibitor with a linker moiety, facilitating the targeted delivery of cytotoxic agents to neoplastic cells. Puxitatug samrotecan drug-linker enables the synthesis of ADCs such as Puxitatug samrotecan, thereby enhancing therapeutic efficacy while minimizing systemic toxicity. This reagent is essential for researchers focusing on innovative cancer therapies and targeted drug delivery systems.
Product Information
Catalog NumA41491
FormulaC60H84N8O20S
Molecular Weight1269.42
CAS Number3025787-81-6
SMILESO=C1N2C(C(C(C2)=C3C4=C5CCC3)=NC4=CC=C5NC([C@H](C)NC([C@H](C(C)C)NC(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCN6C(C(CC6=O)SC[C@H](N)C(O)=O)=O)=O)=O)=O)=O)=CC7=C1COC([C@]7(O)CC)=O
SynonymsAZD8205 drug-linker
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2